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Summary
Nijmegen breakage syndrome (NBS) is a rare autosomal
recessive disorder characterized by microcephaly, a bird-
like face, growth retardation, immunodeficiency, lack of
secondary sex characteristics in females, and increased
incidence of lymphoid cancers. NBS cells display a phe-
notype similar to that of cells from ataxia-telangiectasia
patients, including chromosomal instability, radiation
sensitivity, and aberrant cell-cycle–checkpoint control
following exposure to ionizing radiation. A recent study
reported genetic linkage of NBS to human chromosome
8q21, with strong linkage disequilibrium detected at
marker D8S1811 in eastern European NBS families. We
collected a geographically diverse group of NBS families
and tested them for linkage, using an expanded panel
of markers at 8q21. In this article, we report linkage of
NBS to 8q21 in 6/7 of these families, with a maximum
LOD score of 3.58. Significant linkage disequilibrium
was detected for 8/13 markers tested in the 8q21 region,
including D8S1811. In order to further localize the gene
for NBS, we generated a radiation-hybrid map of mark-
ers at 8q21 and constructed haplotypes based on this
map. Examination of disease haplotypes segregating in
11 NBS pedigrees revealed recombination events that
place the NBS gene between D8S1757 and D8S270. A
common founder haplotype was present on 15/18 dis-
ease chromosomes from 9/11NBS families. Inferred (an-
cestral) recombination events involving this common
haplotype suggest that NBS can be localized further, to
an interval flanked by markers D8S273 and D8S88.
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Introduction
Nijmegen breakage syndrome (NBS; MIM 251260) is a
rare autosomal disorder. The NBS patient registry, main-
tained in Nijmegen, currently contains entries for 53
patients, many of whom are of eastern European de-
scent. The clinical features of the disease include micro-
cephaly from birth, a birdlike face, growth retardation,
immunodeficiency in both humoral and cellular immune
responses, susceptibility to respiratory-tract infections,
lack of secondary sex characteristics in females, and an
increased incidence of lymphoid cancers, primarily lym-
phomas (van der Burgt et al. 1996; Chrzanowska et al.
1997). In vitro, NBS cells are sensitive to radiation and
radiomimetic compounds (Taalman et al. 1983). Pe-
ripheral blood lymphocytes display spontaneous and ra-
diation-induced chromosomal instability that frequently
involves the immunoglobulin and T-cell receptor loci on
chromosomes 7 and 14 (Weemaes et al. 1981; Taalman
et al. 1989). Following exposure to ionizing radiation,
NBS cells are unable to activate the G1 cell-cycle check-
point and are unable to halt progression through the S
phase, a feature termed “radioresistant DNA synthesis”
(Jaspers and Bootsma 1982; Murnane and Painter 1982;
Taalman et al. 1983; Jongmans et al. 1997; Sullivan et
al. 1997). This latter phenotype has been used to classify
NBS cells into two complementation groups, V1 and V2
(Jaspers et al. 1988; Wegner et al. 1988).
Many of the features of NBS are similar to the more
common chromosomal-instability disorder ataxia-tel-
angiectasia (AT). Like NBS, AT patients are character-
ized by radiation sensitivity, radioresistant DNA syn-
thesis, chromosomal instability preferentially involving
chromosomes 7 and 14, immunodeficiency, and in-
creased incidence of lymphoid cancers (Gatti 1998). As
a result, NBS initially was thought to be a clinical variant
of AT, connected by the very rare AT-Fresno syndrome,
which has features of both NBS and AT (Curry et al.
1989). However, substantial evidence now indicates that
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Figure 1 NBS pedigrees. Eleven families with characteristic symptoms of NBS were ascertained from the United States, Poland, Britain,
Spain, The Netherlands, Germany, and Canada. A family’s complementation-group assignment, V1 or V2, is indicated if known. For families
NBS1, NBS6, and NBS16, DNA was available only from the affected individuals. For family NBS18, DNA was available from individuals
NBS1801 and NBS1803.
NBS is genetically distinct from AT. This evidence in-
cludes the observations that fusion of AT and NBS fi-
broblasts results in complementation of radioresistant
DNA synthesis; that transfer of a normal chromosome
11, encoding the ATM gene, into NBS cells does not
complement their radiation sensitivity; and that haplo-
type analysis excludes linkage of NBS to the AT region
at 11q23 (Jaspers et al. 1988;Wegner et al. 1988; Stumm
et al. 1995; Komatsu et al. 1996). In addition, we found
no mutations in the ATM gene in NBS affecteds, using
SSCP analysis (authors’ unpublished data).
Recently, Matsuura et al. (1997) mapped the gene mu-
tated in NBS to human chromosome 8, using microcell-
mediated chromosome transfer. These investigators
found that chromosome 8 complemented radiation sen-
sitivity in both NBS V1 and V2 fibroblasts, which is
consistent with the notion that cells from the two dif-
ferent complementation groups have defects in the same
gene. Analysis of deletion hybrids localized the gene to
8q21-24. Coincidentally, Saar et al. (1997) reported link-
age of NBS to marker D8S1811 on chromosome 8q21
in 14 eastern European families, with a maximum LOD
score of 6.86 at a recombination fraction of zero. A
1-cM minimal region for the NBS gene was identified
between markers D8S271 and D8S270, on the basis of
genetic recombinants. Strong allelic association was re-
ported at D8S1811, suggesting a founder effect for a
common mutation in this population.
We collected a geographically diverse group of NBS
families—from the United States, Canada, England, The
Netherlands, Germany, Poland, and Spain—and tested
these families for linkage to chromosome 8. In this ar-
ticle, we report linkage of NBS to 8q21 in 6/7 NBS
families; furthermore, there is strong evidence of linkage
disequilibrium at D8S1811 and surrounding markers.
Generation of a radiation-hybrid map at 8q21 allowed
us to perform haplotype analysis of 10 markers. Our
results identified both a conserved haplotype among
NBS patients and ancestral recombinants that further




A total of 11 NBS families were collected for this study
(fig. 1). Families NBS6, NBS8, NBS9, NBS12, NBS13,
and NBS18 were collected from Poland (NBS6), the
United States (NBS8), Britain (NBS9), The Netherlands
(NBS12 and NBS13), and Canada (NBS18) and have
been described elsewhere (Weemaes et al. 1981; Conley
et al. 1986; Taalman et al. 1989; Chrzanowska et al.
1995; Green et al. 1995; Der Kaloustian et al. 1996).
Family NBS1 was ascertained from the United States,
by P.K. Families NBS11 and NBS16 were collected by
Cerosaletti et al.: Localization of the NBS Gene to 8q21 127
Table 1

















a Estimated distance from the next marker.
b ND  not determined.
R.A.G. Family NBS11 is from Spain, and family NBS16
was ascertained from the United States. Families NBS14
and NBS15 were ascertained from Germany, by B.S. and
B.H.B., and are of Slavic ancestry. All the patients had
symptoms consistent with a diagnosis of NBS, including
microcephaly, growth retardation, immunodeficiency,
chromosomal instability, and radiation sensitivity and/
or radioresistant DNA synthesis.
Blood samples were obtained from the families by
informed consent, and DNA was prepared by standard
procedures (Sambrook et al. 1989). For families NBS1,
NBS6, and NBS16, DNA was available only from the
affected individuals. For family NBS18, DNA was avail-
able from the father and the affected. In addition, DNA
was limiting for individual NBS1104. To allow analysis,
DNA from NBS1104 was amplified randomly by a pri-
mer-extension–amplification protocol (Zhang et al.
1992) using 25 ng genomic DNA, 40 mM random
15mers, 100 mM dNTPs, 10 mM Tris pH 8.3, 50 mM
KCl, 2.5 mM MgCl2, and 5 U Taq DNA polymerase
(Boehringer Mannheim). PCR was accomplished by
means of 50 cycles of 95C for 1 min, 37C for 2 min,
and 55C for 4 min, with a ramp from 37C to 55C of
10 s/C. For genotyping reactions, 2.5 ml of the resultant
PCR product was used.
Families NBS1, NBS6, NBS9, NBS11, NBS12,
NBS13, and NBS14 were used for linkage studies. The
remaining families—NBS8, NBS15,NBS16, andNBS18,
which were not informative for linkage—were included
in the linkage-disequilibrium and haplotype analyses.
Genotyping
NBS families were genotyped for 13 microsatellite
markers from a 15.3-cM region at 8q21 (table 1). Mark-
ers were assayed by PCR using 20 ng genomic DNA;
0.33 mM spermidine; 50 mM Tris pH 9; 20 mM
(NH4)2SO4; 1.5 mMMgCl2; 40 mMeach of dTTP, dGTP,
and dCTP; 4 mM dATP; 0.1 mCi a[33P]-dATP (Amer-
sham); 0.6 mM each primer; and 0.5 ml Taq DNA poly-
merase. Amplification was accomplished by use of a
touchdown protocol of 65C–55C, followed by 30 cy-
cles of 95C for 1 min, 55C for 1 min, and 72C for 1
min. PCR products were analyzed on 5% acrylamide/8
M urea denaturing gels by use of 1# Tris borate–EDTA
buffer (89 mM Tris borate/2.5 mM EDTA). Electropho-
resis was performed at 50 mA. Gels were dried following
electrophoresis and were autoradiographed. Alleleswere
sized relative to CEPH control 134702, for each marker.
Linkage Analysis
Multipoint linkage analysis was performed by use of
the GENEHUNTER linkage-analysis program (Krug-
lyak et al. 1996), under the assumptions of a fully pen-
etrant autosomal recessive disease, a disease-allele fre-
quency of .001, and no phenocopies. Allele frequencies
were estimated from the NBS parents. The genetic
map order used was D8S286–2 cM–D8S1757–5.5
cM–(D8S271, D8S1707, D8S273)–1.1 cM–(D8S88,
D8S1724, D8S1811, D8S1146, AFMa041xg5, D8S270,
D8S1818)–6.7 cM–D8S506 and was based on the Ge´-
ne´thon map (Dib et al. 1996).
Linkage-Disequilibrium Analysis
Linkage disequilibrium was assessed by use of the
transmission-disequilibrium test (Spielman et al. 1993).
Transmissions of alleles from heterozygous NBS parents
to affected offspring were tabulated for each of the
markers genotyped in families NBS8, NBS9, NBS11,
NBS12, NBS13, NBS14, NBS15, and NBS18. In the case
of family NBS18, in which only the father and the pro-
band were available for testing, transmissions were
scored only if the proband was neither heterozygous for
the same alleles as the parent nor homozygous at a given
marker. This resulted in a maximum of 19 informative
transmissions that could be scored at each marker. Sig-
nificant evidence of transmission disequilibrium was as-
sessed by performance of a two-sided Fisher’s exact test.
Radiation-Hybrid Mapping
A radiation-hybrid map spanning D8S271–D8S1818
was generated by scoring for the presence of markers
D8S271, D8S1707, D8S273, D8S88, D8S1724,
D8S1811, D8S1146, AFMa041xg5, D8S270, and
D8S1818 in the Stanford G3 and TNG3 radiation-hy-
brid panels (Research Genetics). The G3 radiation-hy-
brid panel was generated with 10,000 rads of ionizing
radiation, and the TNG3 panel was generated with
50,000 rads of radiation. For each marker, 35 or 25 ng
of DNA from each of the hybrids (G3 or TNG3 panels,
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Figure 2 Multipoint linkage analysis of the NBS locus andmark-
ers at 8q21. SevenNBS families—namely, NBS1, NBS6,NBS9,NBS11,
NBS12, NBS13, and NBS14—were genotyped for 13 microsatellite
markers at 8q21. Multipoint linkage analysis was performed by use
of the GENEHUNTER linkage-analysis program. Map order and dis-
tances were obtained from the Ge´ne´thon genetic map. “D8S271/S273”
represents the cluster of markers D8S271-D8S1707-D8S273, and
“D8S1811/S270” represents the cluster of markers D8S88-D8S1724-
D8S1811-D8S1146-AFMa041xg5-D8S270-D8S1818.
respectively) and the human and rodent controls was
amplified with 0.6 mM each primer, 0.33 mM spermi-
dine, 50 mM Tris pH 9, 20 mM (NH4)2SO4, 1.5 mM
MgCl2, 40 mM each dNTP, and 0.5 ml Taq DNA poly-
merase. Amplification was accomplished by use of a
touchdown protocol of 65C–55C, followed by 30 cy-
cles of 95C for 1 min, 55C for 1 min, and 72C for 1
min. PCR products were analyzed by agarose-gel elec-
trophoresis and were scored as “positive,” “negative,”
or “undetermined.” Analysis of the retention patterns
of the markers in the TNG3 and G3 hybrid panels was
accomplished by performance of a joint analysis using
the RHMAP program (Lunetta et al. 1996), under the
assumptions of a common retention probability for all
fragments in the same panel and nonproportional in-
termarker distances in different panels.
Haplotype Analysis
Haplotypes were constructed for the affecteds in all
the NBS families, on the basis of the following map
order: D8S286-D8S1757-D8S1707-D8S273-D8S1724-
D8S1811-D8S88-D8S270-D8S1818-D8S506. The loca-
tions of D8S286, D8S1757, and D8S506 were set on
the basis of the genetic map, whereas D8S1707, D8S273,
D8S1724, D8S1811, D8S88, D8S270, and D8S1818
were ordered by radiation-hybrid mapping. To identify
an ancestral haplotype, disease chromosomes bearing
the 15 allele at D8S1811 were compared, taking into
account the allelic association observed at markers
throughout the region. For families NBS6 and NBS16,
where the parents were unavailable for determination of
the phase of the chromosomes in the affecteds, the phase
was constructed to maintain the ancestral haplotype
over the largest region of the chromosome.
Results
Linkage to Markers at 8q21 in the NBS Families
A total of 11 families—from the United States, Can-
ada, England, Spain, The Netherlands, Germany, and
Poland—with characteristic symptoms of NBS were as-
certained (fig. 1). In some cases, the complementation-
group status of a family had been determined; however,
families were grouped together for analysis irrespective
of their complementation-group assignment, on the basis
of the observation that chromosome 8 complements
both V1 and V2 NBS fibroblasts (Matsuura et al. 1997).
Saar et al. (1997) previously reported linkage tomark-
ers on chromosome 8q21 in a collection of predomi-
nantly Polish NBS families. To confirm and extend these
results, 13 microsatellite markers from a 15.3-cM region
at 8q21 (table 1) were genotyped in seven of the NBS
families in this geographically diverse group. Evidence
for linkage was assessed by use of the program GENE-
HUNTER (Kruglyak et al. 1996). Figure 2 shows the
results of the multipoint analysis. The maximum mul-
tipoint LOD score detected was 3.58. Six of the seven
NBS families had positive LOD scores in this region.
Linkage to markers at 8q21 was not detected for one
consanguineous family, NBS1, represented by a single
affected individual. When this family was excluded, a
maximum LOD score of 4.28 was obtained. The max-
imum LOD score was not affected appreciably by chang-
ing the map order and map distances to incorporate
aspects of the subsequently determined radiation-hybrid
map of the region, suggesting that the linkage to 8q21
was robust (range 3.51–3.62).
Linkage Disequilibrium at 8q21
Strong linkage disequilibrium has been observed at
marker D8S1811 in eastern European NBS families
(Saar et al. 1997). To determine if allelic association
could be detected in our collection of NBS families, a
transmission-disequilibrium test was performed (table
2). Eight of the 13 markers at 8q21 that were genotyped
in these families showed significant evidence of linkage
disequilibrium ( ). Striking linkage disequilibriumP ! .01
was detected at markers D8S1724, D8S1811, and
D8S88 ( ). The peak linkage disequilibrium ap-P ! .0001
peared to be at D8S1811, where the 15 allele was trans-
Table 2
Transmission-Disequilibrium Test for Markers at 8q21 in NBS Families
Marker
and Status No. of Each Allele
Total No.
of Alleles P Valuea
D8S286: 1 3 5 6 7 8 9 10 12
Transmitted 1 4 0 7 4 0 0 2 0 18 .0145
Not transmitted 0 2 1 2 4 5 3 0 1 18
D8S1757: 1 6 7 10 11 12 15
Transmitted 2 3 7 0 3 2 0 17 .0001
Not transmitted 0 5 0 7 0 3 2 17
D8S271: 1 2 4 5 6 7 8
Transmitted 4 3 0 0 2 4 2 15 .0052
Not transmitted 4 0 2 1 8 0 0 15
D8S1707: 1 4 5
Transmitted 2 5 4 11 .4374
Not transmitted 4 2 5 11
D8S273: 1 2 3 4 5 7
Transmitted 3 1 7 0 0 1 12 .0788
Not transmitted 5 2 1 2 1 1 12
D8S1724: 4 5 6 7 9
Transmitted 2 0 0 11 1 14 !.0001
Not transmitted 1 1 12 0 0 14
D8S1811: 2 3 5 12 14 15
Transmitted 4 0 0 0 1 14 19 !.0001
Not transmitted 12 1 1 4 1 0 19
D8S88: 4 5 6 7 8 9 11 12
Transmitted 2 2 0 0 13 0 1 0 18 !.0001
Not transmitted 3 2 6 2 0 2 0 3 18
AFMa041xg5: 1 2 5
Transmitted 6 0 0 6 .0022
Not transmitted 0 5 1 6
D8S1146: 1 2 3 4 5
Transmitted 2 8 0 0 0 10 .0073
Not transmitted 1 2 1 1 5 10
D8S270: 1 2 5 6 7 8
Transmitted 0 1 2 1 6 9 19 .0001
Not transmitted 4 1 5 6 3 0 19
D8S1818: 1 2 3
Transmitted 4 3 4 11 1.0000
Not transmitted 4 3 4 11
(continued)
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Table 2 (continued)
Marker
and Status No. of Each Allele
Total No.
of Alleles P Valuea
D8S506: 1 2 3 4
Transmitted 1 7 6 0 14 .0192
Not transmitted 4 1 6 3 14
a Calculated by use of a two-sided Fisher’s exact test.
mitted exclusively to affected offspring a total of 14
times. This allele corresponds to the 108-bp allele pre-
viously reported to be in linkage disequilibrium in east-
ern European NBS families (Saar et al. 1997). In addition
to these three markers, strong linkage disequilibrium
also was detected at D8S1757 and D8S270 (P 
)..0001
Generation of a Radiation-Hybrid Map at 8q21
The genetic map at 8q21 fails to order many markers
in the region, particularly between D8S1757 and
D8S1818, where the greatest evidence for linkage toNBS
was detected (fig. 2). In order to improve the resolution
of the genetic map of this region, genotype data from
our NBS families were combined with genotype data
from 11 CEPH families. However, this approach did not
refine the map significantly.
As an alternative approach, we generated a radiation-
hybrid map at 8q21. Markers D8S271, D8S1707,
D8S273, D8S1724, D8S1811, D8S88, D8S1146,
AFMa041xg5, D8S270, and D8S1818 were typed in the
Stanford G3 and TNG3 radiation-hybrid panels. These
hybrid panels were generated with 10,000 and 50,000
rads of ionizing radiation, to yield resolutions of ∼500
kb and ∼100 kb, respectively. A joint analysis of the
results was performed by use of the RHMAP program
(Lunetta et al. 1996). For six of the loci tested, a 1,000:
1 framework map was determined as follows: D8S1707-
D8S273-D8S1724-D8S88-D8S270-D8S1818 (fig. 3).
This framework map was fixed, and each of the four
remaining markers was added individually. This analysis
placed D8S1811 between D8S1724 and D8S88, at 394:
1 odds, but did not provide an unambiguous location
for D8S271, D8S1146, and AFMa041xg5. The dis-
tances, in centirays (cR), for the map in each of the
radiation-hybrid panels are shown in figure 3. The total
map length in the G3 panel was 219.8 cR. This corre-
sponds to 8,133 kb, when the average value of 37 kb/
cR reported for chromosome 8 in the G3 panel (Stewart
et al. 1997) is used, which contrasts with the genetic
distance of 1.1 cM for this region.
Identification of a Minimal NBS Region, by
Haplotype Analysis
The radiation-hybrid–map order given above was
used to define haplotypes in the NBS families, for the
purpose of identifying the minimal region that could
contain the NBS gene. For this analysis, only thosemark-
ers that could be ordered with robust odds in the ra-
diation-hybrid map or those that could be ordered in
the genetic map were considered. The haplotypes for 14
NBS affecteds are presented in figure 4.
Four recombinant chromosomes were identified in our
NBS families. NBS1208 and NBS1303 both had recom-
bination events between D8S1757 and D8S1707, setting
the proximal boundary for the NBS gene at D8S1757.
For the distal side, NBS603 had a recombination event
between D8S88 and D8S270, and NBS905 had a re-
combination event between D8S1818 and D8S506.
These results place the NBS gene in the interval between
D8S1757 and D8S270.
Since strong linkage disequilibrium was detected at
markers in the NBS region, we specifically compared
disease chromosomes bearing the 15 allele at D8S1811.
A single conserved haplotype encompassing markers
D8S1724 (7 allele), D8S1811 (15 allele), D8S88 (8 al-
lele), and D8S270 (8 allele) was identified (fig. 4), which
is consistent with the extent of linkage disequilibrium in
the region. For some NBS-patient chromosomes, it was
possible to infer ancestral recombination events in the
conserved haplotype by identification of markers for
which the disease-associated allele has been lost. In order
to be conservative in this approach, we did not consider
cases such as D8S88 in NBS6 or D8S1811 in NBS1603,
for which the disease-associated allele for a singlemarker
has been replaced with an allele differing by only one
repeat unit, since these instances simply could represent
mutations at the marker locus. In this analysis, NBS803
had an apparent ancestral recombination event between
D8S1811 and D8S88, replacing the 8 allele at D8S88
with the 11 allele. Since no linkage disequilibrium was
detected at D8S273, these results suggest that the region
containing the NBS gene can be limited further to the
interval between D8S273 and D8S88, a distance of 64.7
cR in the G3 radiation-hybrid panel.
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Figure 3 Radiation-hybridmap ofmarkers at 8q21. Tenmarkers
between D8S271 and D8S1818 were typed in the Stanford G3 and
TNG3 radiation-hybrid panels, and the results were analyzed by per-
formance of a joint analysis with the RHMAP program. A 1,000:1
framework map was established for the six loci indicated in boldface
type. The distances calculated for this map, in both radiation-hybrid
panels, are shown to the right. The location of D8S1811, relative to
D8S1724, in the framework map is indicated to the left, with the most
likely position, between D8S1724 and D8S88, represented by a like-
lihood ratio of 1.0 and the next-most-favored location represented by
a likelihood ratio of 393.7.
In addition to chromosomes bearing the ancestral hap-
lotype, eight chromosomes that did not carry the 15
allele at D8S1811 were identified (fig. 4). Consistentwith
the absence of linkage of NBS1 to markers at 8q21,
NBS108 had unique alleles at D8S1811 (alleles 1 and
11) and was heterozygous for most markers across the
region. NBS1503 had one chromosome carrying the 14
allele at D8S1811. This chromosome possibly may bear
the ancestral haplotype, since the 8 allele is present at
D8S88, and the difference of one repeat unit at D8S1811
could be due to mutation. NBS1303 was homozygous
at markers between D8S1707 and D8S506, with the 2
allele at D8S1811. The nonconserved chromosomes in
NBS904, NBS905, and NBS1803 also carried the 2 allele
at D8S1811. However, there was no evidence of a shared
haplotype on these chromosomes. Thus, these chro-
mosomes may carry distinct mutations in the NBS gene.
Discussion
We detected linkage of NBS to markers at 8q21, with
a maximum LOD score of 3.58, in seven NBS families
from different geographical regions. These results con-
firm those of Saar et al. (1997), who reported linkage
of NBS to markers at 8q21 in 14 eastern European NBS
families. Interestingly, one family, represented by a single
consanguineous proband (NBS108), did not show link-
age to 8q21. This proband was first evaluated at 16 mo
of age and was observed to have microcephaly, growth
retardation, unusual facial features, mild radial cata-
racts, and diffuse abnormal skin pigmentation, including
cafe´-au-lait spots. He has suffered from recurrent minor
infections and fevers, although an initial immunological
evaluation revealed normal immunoglobulin levels and
no T-cell or B-cell abnormalities. An in-depth cytogenetic
analysis showed increased spontaneous chromosomal
breakage in primary fibroblast cultures, as well as an
increase in chromosomal aberrations following treat-
ment of lymphocytes, with bleomycin. A chromosomal
translocation involving chromosome 7, t(7;7)(p15;q36),
was observed in phytohemagglutinin-stimulated lym-
phocytes, although the frequency of the aberrations was
within normal limits. Lymphocytes from this individual
were radiation sensitive at levels comparable to those
for AT homozygotes (Huo et al. 1994). With the excep-
tion of the cataracts, these features are typical of NBS.
A diagnosis of AT was excluded because of the absence
of ataxia, normal serum alphafetoprotein levels, and het-
erozygosity at microsatellite markers from the ATM lo-
cus at 11q23. In addition, we failed to find any muta-
tions in the ATM gene in NBS108, by SSCP analysis.
Thus, the absence of linkage to 8q21 in family NBS1
suggests the possibility of genetic heterogeneity in NBS.
Despite the diverse origins of our collection of NBS
families, strong linkage disequilibrium was detected at
multiple markers in the 8q21 region. In particular, we
observed association with the same allele at D8S1811
as that reported for the eastern European NBS families.
By mapping and genotyping additional markers in the
region, we were able to define a conserved haplotype on
chromosomes bearing the 15 allele at D8S1811. Among
our 11 NBS families, 6 were homozygous for this hap-
lotype, whereas 3 more were heterozygous. Only one
proband (NBS1303) whose family was consistent with
linkage to 8q21 did not carry the conserved haplotype
on either parental chromosome. These results indicate
the presence of a strong founder effect, presumably of
Slavic origin, in NBS. It is likely that chromosomes car-
rying the ancestral haplotype will have a single conserved
mutation. In contrast, there was no evidence of a shared
haplotype among chromosomes in the remaining NBS
families, which did not carry the ancestral haplotype.
These chromosomes appear to represent at least four
novel NBS mutations.
In their initial report of linkage, Saar et al. (1997)
identified an NBS minimal region between D8S271 and
D8S270, a 1-cM interval based on the Ge´ne´thon map.
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Figure 4 Haplotypes of NBS affecteds, at 8q21. Haplotypes for 14 NBS affecteds were constructed by use of the 10 markers (shown at
left) that were ordered unambiguously in the genetic and radiation-hybrid maps. The specific alleles detected at each marker are shown for
each individual, and parental chromosomes are boxed. Truncations of the boxes indicate genetic recombination events that excluded linkage.
The conserved founder haplotype identified on chromosomes carrying the 15 allele at D8S1811 is indicated by gray shading. Individual markers
within this ancestral haplotype that differ by a single repeat length are indicated by stippling. The arrowheads indicate inferred ancestral
recombination events that appear to demarcate the minimal region encoding the NBS gene.
We expanded our analysis by genotyping 10 additional
markers within the D8S271–D8S270 interval in our
NBS families. Haplotypes constructed with these addi-
tional markers identified genetic recombinants that place
the NBS gene between D8S1757 and D8S270. We were
able to limit the region further by identifying a conserved
haplotype present on disease chromosomes and inferring
ancestral recombination events that altered the distal
boundary of the conserved haplotype. These results sug-
gest a new minimal NBS region between D8S273 and
D8S88, encompassing the markers D8S1724 and
D8S1811. This is a distance of !1 cM, or 65 cR, based
on the G3 radiation-hybrid panel.
Our study also provides a more refined map of the
8q21 region. We were successful in ordering 7/10 unor-
dered markers between D8S271 and D8S270 in the ge-
netic map, using radiation-hybrid mapping. This radi-
ation-hybrid map is in agreement with the Whitehead
Institute doubly linked contig map WC-449, for those
markers tested in common, with one exception: the
Whitehead Institute map places D8S88 and D8S1811
proximal to D8S1724. At this time, we cannot distin-
guish between these two map orders, on the basis of our
preliminary physical mapping of the region (Cooper et
al. 1997). If the Whitehead Institute order is correct, the
NBS minimal region would be between D8S88 and
D8S270, but this region still would encompass markers
D8S1811 and D8S1724. The most surprising outcome
of the radiation-hybrid mapping, however, was the es-
timated size of the region D8S1707–D8S1818. Although
this region is only 1.1 cM in length on the genetic map,
the radiation-hybrid analysis generated a length of 220
cR in the G3 radiation-hybrid panel. By use of the av-
erage value 37 kb/cR, reported for chromosome 8 (Stew-
art et al. 1997), this corresponds to a distance of 8.1
Mb. Our physical mapping at 8q21 supports the notion
that the region is larger than suggested by the genetic
map but not to the extent indicated by the radiation-
hybrid mapping (Cooper et al. 1997).
One puzzle that remains to be solved for NBS is why
the disease is so rare, with most cases being accounted
for by individuals carrying the conserved haplotype on
both parental chromosomes. Perhaps an ascertainment
bias exists, since the disease is not well known and many
individuals with NBS may not have been diagnosed.
Currently, the majority of cases in the NBS registry were
identified at a small number of clinical centers. It is pos-
sible that more cases will be identified as work continues
on the mapping and cloning of the gene mutated in NBS.
An alternative explanation is that the symptoms asso-
ciated with NBS are unique to the mutation present on
the conserved haplotype. Other mutations in the same
gene may cause different symptoms or may be lethal.
Identification of new cases with nonconserved haplo-
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types, as well as cloning of the gene and generation of
knockout animals, may shed some light on this puzzle.
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